Reaads Igm Anti-B2GPI Test Kit, Model 038-001

by Corgenix, Inc.

510(k) K031208

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

in data synced 11 Oct 2026

Documents

510(k) K031208↗

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 11 Oct 2026. What this means

Regulatory status

as of registry sync 11 Oct 2026

Region	Authorization	Number	Date	Status
United States	FDA 510(k)SESE Substantially Equivalent · Special	NumberK031208	Date7 Jul 2003Cleared	StatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 11 Oct 2026.

Coverage

1 jurisdiction

Active
Expiring
Withdrawn
Listed
Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number: K031208
FDA Product Code: MSV

Device Class: Class II
Regulation: 21 CFR Part 866.5660
Advisory Committee: Immunology
FDA Decision: SESE Substantially Equivalent

Other devices from Corgenix, Inc.

Reaads Igg Anti-B2GPI Test Kit

Class II
Modification to Reaads Anti-Phosphatidylserine Iga Semi-Quantative Test Kit

Class II
Reeads Anti-Phosphatidylserine Igg/Igm Semi-Quantitative Test Kit

Class II
Reaads Igg Anti-Prothrombin Semi-Quantitative Test Kit

Class II
REAADS Anti-Cardiolipin IgG/IgM Semi-Quantitative Test Kit, Model 023-001

Class II
Rhigene Hep-Ana Test System

Class II

See all devices from Corgenix, Inc. →